Compulsory screening for Italian newborns:
This article was originally published in Clinica
Italy has introduced compulsory screening for hypothyroidism and phenylketonuria in newborns, according to a report in the August 14 issue of The Lancet. Blood tests will be carried out between the third and fifth day after birth and the samples will be forwarded to a regional screening centre within 48 hours. The centres, which are each expected to process at least 60,000 samples a year, will also offer counselling to parents who are symptom-free carriers of genetic defects. The initiative also includes early diagnosis of congenital malformations and experimental screening for cystic fibrosis.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.